Negev Capital
Negev Capital is a Cayman-based venture capital firm that backs healthcare, life sciences, and technology ventures, with a focus on psychedelic medical interventions. It targets early-stage drug discovery programs, especially preclinical and Phase 1 development, and supports companies with strong management, scientific teams, and robust intellectual property. The firm seeks to advance the thoughtful and therapeutic use of psychedelic medications to treat neuropsychiatric disorders and to help these treatments reach patients in need, contributing to the maturation of the field.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Intellectual Property
Filament Health
Post in 2025
Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.
Filament Health
Post in 2024
Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.
Filament Health
Post in 2023
Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.
Filament Health
Funding Round in 2022
Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.